Two National Groups Partner to Develop Shared IBD Decision-making Program

Two National Groups Partner to Develop Shared IBD Decision-making Program
The Crohn’s & Colitis Foundation and the American Gastroenterological Association (AGA) are collaborating with Pfizer to develop a program that aims to jumpstart advances in the area of shared decision-making in inflammatory bowel diseases (IBDs). The program is designed to identify gaps and needs in effective patient-provider communication and where research not been enough to

Knowledge is power when living with IBD.

Get access to the web’s leading IBD news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.


  1. Craig says:

    This is really needed. Some times I think I know more about IBD than my doctor and my doctor is unwilling to take my wishes into consideration as far as treatments are concerned. She doesn’t seem to care what medicines I am ok with and which ones I am not. I have had Biologics pushed on me and I don’t want anything to do with them, as I am not willing to take a chance on getting cancer, heart failure, sepsis or any of the other things that have been linked to them and I have been told that a low dose of steroid is way more harmful than those medications and yet I have had no ill effects from the steroids. Doctor’s need to listen more to what their patients want and not be concerned about what they want. I am the one who has to live with the disease not them.

  2. MiMi says:

    I agree with Craig. I continue to have biologics pushed on me even though the evidence is they are causing strictures and the test clearly does not show any improvement with the inflammation. A low dose of Prednisone has provided some relief and I am being treated like I want narcotics. I have not had any serious side effects from Prednisone. I am being pushed to have a colostomy bag and then still take a biologics. I want to have a say in my treatment.

Leave a Comment

Your email address will not be published. Required fields are marked *